Diphlorethohydroxycarmalol inhibits melanogenesis via protein kinase A/cAMP response element‐binding protein and extracellular signal‐regulated kinase‐mediated microphthalmia‐associated transcription factor downregulation in α‐melanocyte stimulating hormone‐stimulated B16F10 melanoma cells and zebrafish